Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Western Uranium & Vanadium (WSTRF) Cash & Equivalents (2016 - 2025)

Western Uranium & Vanadium (WSTRF) has disclosed Cash & Equivalents for 8 consecutive years, with $3.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 4151.6% to $3.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.2 million, a 4151.6% increase, with the full-year FY2024 number at $5.5 million, up 7202.87% from a year prior.
  • Cash & Equivalents was $3.2 million for Q3 2025 at Western Uranium & Vanadium, up from $75057.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $11.2 million in Q2 2022 to a low of $75057.0 in Q3 2021.
  • A 5-year average of $3.7 million and a median of $2.8 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 13847.79% in 2022, then plummeted 99.28% in 2023.
  • Western Uranium & Vanadium's Cash & Equivalents stood at $75057.0 in 2021, then changed by 0.0% to $75057.0 in 2022, then grew by 0.02% to $75075.0 in 2023, then soared by 7202.87% to $5.5 million in 2024, then plummeted by 41.78% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for WSTRF's Cash & Equivalents are $3.2 million (Q3 2025), $75057.0 (Q2 2025), and $2.8 million (Q1 2025).